Log in to save to my catalogue

Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer

Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4533880

Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer

About this item

Full title

Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer

Publisher

London: BMJ Publishing Group Ltd and British Society of Gastroenterology

Journal title

Gut, 2012-12, Vol.61 (12), p.1733-1743

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd and British Society of Gastroenterology

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Background Hepatocellular carcinoma (HCC) is a typical inflammation-associated cancer, but may also provoke antitumour immune responses whose significance and underlying mechanisms are incompletely understood. Objective To characterise immune responses in the diethylnitrosamine (DEN)-liver cancer mouse model. Design Tumour development and immune ce...

Alternative Titles

Full title

Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4533880

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4533880

Other Identifiers

ISSN

0017-5749

E-ISSN

1468-3288

DOI

10.1136/gutjnl-2011-301116

How to access this item